Systemic sclerosis and its pulmonary complications in The Netherlands: An epidemiological study

Annals of the Rheumatic Diseases

Volumn 68, Issue 6, 2009, Pages 961-965

  Vonk, M C ^a   Broers, B ^b   Heijdra, Y F ^a   Ton, E ^c   Snijder, R ^d   Van Dijk, A P J ^a   Van Laar, J M ^e   Bootsma, H ^f   Van Hal, P Th W ^g   Van Den Hoogen, F H J ^a   Van Daele, P L A ^g  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUESTIONNAIRE; SCREENING; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; LUNG; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PULMONARY FIBROSIS; QUESTIONNAIRES; REGISTRIES; SCLERODERMA, SYSTEMIC; SEX DISTRIBUTION; TOTAL LUNG CAPACITY; YOUNG ADULT;

EID: 67449168646     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.091710     Document Type: Article

References (37)

1. Furst DE, Clements PJ. Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol 1997;24:53-57 (Pubitemid 27223600)
2. Medsger TA, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Arthritis Rheum 1971;14:714-721
3. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-1093 (Pubitemid 37323574)
4. Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994;37:1283-1289 (Pubitemid 24320744)
5. Tashkin DP, Elashoff R, Clements PJ, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-2666 (Pubitemid 43920839)
6. Alamanos Y, Tsifetaki N, Voulgari PV, et al. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthr Rheum 2005;34:714-720
7. Allcock RJ, Forrest I, Corris PA, et al. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 2004;43:596-602. (Pubitemid 38628190)
8. Arnett FC, Howard RF, Tan F, et al. Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996;39:1362-1370
9. Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology 2006;45:3-4. (Pubitemid 44446764)
10. Le Guern V, Mahr A, Mouthon L, et al. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 2004;43:1129-1137 (Pubitemid 39232818)
11. Mayes MD. Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol 1997;9:557-561 (Pubitemid 27504213)
12. Mayes MD, Lacey JV, Beebe-Dimmer J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-2255 (Pubitemid 36959206)
13. Steen VD, Oddis CV, Conte CG, et al. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997;40:441-445
14. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis - a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-3800 (Pubitemid 41798217)
15. Badesch DB, Tapson VF, McGoon MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - a randomized, controlled trial. Ann Intern Med 2000;132:425-434 (Pubitemid 30149039)
16. Simonneau G, Barst RJ, Galie N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2002;165:800-804 (Pubitemid 34229650)
17. Denton CP, Humbert M, Rubin L, Black CM. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheum Dis 2006;65:1336-1340 (Pubitemid 44620443)
18. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903. (Pubitemid 34984638)
19. Barst RJ, Langleben D, Frost A, et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;169:441-447 (Pubitemid 38187114)
20. Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157 (Pubitemid 41653106)
21. Hoyles RK, Ellis RW, Wellsbury J, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in sleroderma. Arthritis Rheum 2006;54:3962-3970 (Pubitemid 44955900)
22. Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004;43:461-466 (Pubitemid 38489363)
23. Steen V, Medsger TA. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516-522 (Pubitemid 36278021)
24. Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126(Suppl):4S-6S.
25. Vonk MC, Sander MH, van den Hoogen FH, et al. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr 2007;8:317-321 (Pubitemid 47338268)
26. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee. Preliminary criteria for the classification of systemic-sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590
27. Leroy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-1576 (Pubitemid 32660630)
28. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-2242 (Pubitemid 41697286)
29. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentgenol 1997;169:977-983 (Pubitemid 27406888)
30. Matucci-Cerinic A, D'Angelo S, Denton CP, et al. Assessment of lung involvement. Clin Exp Rheumatol 2003;21(Suppl 29):S19-23. (Pubitemid 41116906)
31. Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 2002;122:524-527 (Pubitemid 35002130)
32. Vonk MC, van Dijk APJ, Heijdra YF, et al. Pulmonary hypertension: its diagnosis and management, a multidisciplinary approach. Netherland J Med 2005;63:193-198 (Pubitemid 40903968)
33. Roberts-Thomson PJ, Jones M, Hakendorf P, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 2001;31:220-229 (Pubitemid 32592649)
34. Silman A, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-290 (Pubitemid 18196560)
35. Battle RW, Davitt MA, Cooper SM, et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996;110:1515-1519 (Pubitemid 26425153)
36. Chang B, Wigley FM, White B, Wise RA. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003;30:2398-2405 (Pubitemid 37413900)
37. Walker UA, Tyndall A, Czirjak L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research Group database. Ann Rheum Dis 2007;66:754-763 (Pubitemid 46846694)